Search
forResearch 10 of 1000+
- A rapid method for obtaining finasteride, a 5α-reductase inhibitor, from commercial tablets
- STABILITY-INDICATING MICELLAR ELEKTROKINETIC CHROMATOGRAPHY METHOD FOR DETERMINATION OF FINASTERIDE IN PHARMACEUTICAL PREPARATIONS
- Validation of Finasteride Tablets USP by HPLC Isocratic with UV Detector
- Self-Emulsifying Drug Delivery Systems (SEDDS): Measuring Energy Dynamics to Determine Thermodynamic and Kinetic Stability
- Contact dermatitis due to minoxidil
- Development of Stable and Simple Finasteride 333-μg/mL Suspensions that Minimize Occupational Exposure.
- Development and validation of a reversed-phase HPLC method for simultaneous determination of doxazosin mesylate and finasteride
- A STABILITY-INDICATING HPLC METHOD TO DETERMINE FINASTERIDE IN A TABLET FORMULATION
- Determination of Finasteride in Tablets by High Performance Liquid Chromatography
- Effect of Kuntai Capsule Combined with Nilestriol Tablets in the Treatment of Perimenopausal Syndrome and on Reproductive Hormones
Learn 1 of 4
All learn results →Community 3 of 11
- Just saw this in a commercial, bros, is it real? does it work? how does it compare to min and fin and has Kevin Mann said anything?
- What's realistically the earliest pp405 becomes commercially available?
- Following the recent IPO and the positive Phase 3 clinical data for VDPHL01 (extended-release oral minoxidil), what is the projected timeline for the FDA submission and the subsequent commercial availability on the market?